Faculty of Applied sciences and Biotechnology, Shoolini University of Biotechnology and Management Sciences, Distt. Solan, Himachal Pradesh, India.
Department of Biotechnology, Chandigarh Group of Colleges, Mohali, Punjab, India.
Nat Prod Res. 2022 Sep;36(17):4532-4535. doi: 10.1080/14786419.2021.1990917. Epub 2021 Nov 26.
Hypertension has been a significant cause of death due to elevated blood pressure worldwide. The results of molecular docking showed out of selected 40 compounds, chasmanthin (-11.05 kcal/mol), and palmarin (-11.22 kcal/mol) showed strong binding with angiotensin-converting enzyme (ACE) target. The inhibitory action of the selected phytocompounds for ACE protein was also validated by comparing it with the reference drugs, lisinopril (-9.42 kcal/mol), and enalapril (-5.07 kcal/mol). MD simulations study of 100 ns also demonstrated stability of chasmanthin, and palmarin within the active sites of ACE protein. Molecular mechanics generalised born surface area (MMGBSA) analysis of MD trajectories exhibited significant binding of palmarin with ACE (dG Bind= -38.65 ± 2.59 kcal/mol) and chasmanthin (dG Bind= -37.64 ± 2.67 kcal/mol). Drug likeness and pharmacokinetics properties of palmarin and chasmanthin was also found to be permissible, thereby suggesting the use of chasmanthin and palmarin as a novel target inhibitor against ACE protein to combat hypertension.
高血压是全球范围内因血压升高而导致死亡的主要原因。分子对接的结果表明,在所选择的 40 种化合物中,chasmanthin(-11.05kcal/mol)和palmarin(-11.22kcal/mol)与血管紧张素转化酶(ACE)靶标具有很强的结合能力。所选植物化合物对 ACE 蛋白的抑制作用也通过与参考药物(赖诺普利(-9.42kcal/mol)和依那普利(-5.07kcal/mol))进行比较来验证。100ns 的 MD 模拟研究也证明了 chasmanthin 和 palmarin 在 ACE 蛋白的活性部位的稳定性。MD 轨迹的分子力学广义 Born 表面积(MMGBSA)分析显示,palmarin 与 ACE 结合(dG Bind= -38.65±2.59kcal/mol)和 chasmanthin(dG Bind= -37.64±2.67kcal/mol)具有显著的结合能力。还发现 palmarin 和 chasmanthin 的药物相似性和药代动力学特性是允许的,因此建议使用 chasmanthin 和 palmarin 作为 ACE 蛋白的新型靶标抑制剂,以对抗高血压。